Literature DB >> 21844233

Impact of toll-like receptor 2 deficiency on immune responses to mycobacterial antigens.

Muhammad J Rahman1, Olga D Chuquimia, Dagbjort H Petursdottir, Natalia Periolo, Mahavir Singh, Carmen Fernández.   

Abstract

In the present study, we addressed the question of whether Toll-like receptor 2 (TLR2)-mediated innate immunity can contribute to the development of acquired immune responses. We immunized TLR2(-/-) and wild-type (WT) mice three times subcutaneously with the mycobacterial antigen (Ag19kDa) (a TLR2 ligand) or Ag85A (not a TLR2 ligand). One week after the last immunization, sera and spleens were collected. To evaluate cellular responses, we measured gamma interferon (IFN-γ) after in vitro restimulation of spleen cells with antigen alone or antigen-pulsed bone marrow-derived macrophages (BMM(Ag)) or pulmonary macrophages (PuM(Ag)). Antibody responses were comparable in the two mouse strains, but we observed differences in the cellular responses. Recall responses to Ag85A were similar in the two strains, but responses to Ag19kDa given alone or presented by BMM or PuM were lower in TLR2(-/-) than in WT mice. The largest differences in cellular responses were observed when Ag19kDa was presented by PuM. To understand this, we analyzed phenotypic and functional differences between BMM and PuM upon stimulation with various ligands. Generally, PuM had a lower response to the TLR2 ligand Pam(3)Cys-Ser-(Lys)(4) trihydrochloride and to anti-CD40 than BMM, as measured by cytokine secretion and upregulation of costimulatory molecules. This might provide a partial explanation for the lower capacity of PuM when pulsed with Ag19kDa, also a TLR2 ligand. Altogether, our results revealed weaknesses in the T cell and antigen-presenting cell (APC) compartments of the Ag19kDa-immunized TLR2(-/-) mice but indicated that specific immune responses could be generated in the absence of TLR2 regardless of the characteristics of the antigen used.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21844233      PMCID: PMC3257930          DOI: 10.1128/IAI.05724-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

Review 1.  T cell-dendritic cell immunological synapses.

Authors:  Michael L Dustin; Su-Yi Tseng; Rajat Varma; Gabriele Campi
Journal:  Curr Opin Immunol       Date:  2006-06-13       Impact factor: 7.486

Review 2.  Expression and function of Toll-like receptors in T lymphocytes.

Authors:  Dieter Kabelitz
Journal:  Curr Opin Immunol       Date:  2006-11-28       Impact factor: 7.486

3.  TLR2 but not TLR4 signalling is critically involved in the inhibition of IFN-gamma-induced killing of mycobacteria by murine macrophages.

Authors:  J Arko-Mensah; E Julián; M Singh; C Fernández
Journal:  Scand J Immunol       Date:  2007-02       Impact factor: 3.487

4.  Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response.

Authors:  Philip T Liu; Steffen Stenger; Huiying Li; Linda Wenzel; Belinda H Tan; Stephan R Krutzik; Maria Teresa Ochoa; Jürgen Schauber; Kent Wu; Christoph Meinken; Diane L Kamen; Manfred Wagner; Robert Bals; Andreas Steinmeyer; Ulrich Zügel; Richard L Gallo; David Eisenberg; Martin Hewison; Bruce W Hollis; John S Adams; Barry R Bloom; Robert L Modlin
Journal:  Science       Date:  2006-02-23       Impact factor: 47.728

5.  Immunization with a Toll-like receptor 7 and/or 8 agonist vaccine adjuvant increases protective immunity against Leishmania major in BALB/c mice.

Authors:  Wen-Wei Zhang; Greg Matlashewski
Journal:  Infect Immun       Date:  2008-05-12       Impact factor: 3.441

6.  A Toll-like receptor-2-directed fusion protein vaccine against tuberculosis.

Authors:  Baolin Wang; Marcela Henao-Tamayo; Marisa Harton; Diane Ordway; Crystal Shanley; Randall J Basaraba; Ian M Orme
Journal:  Clin Vaccine Immunol       Date:  2007-07

Review 7.  Immunology of tuberculosis.

Authors:  Laurent P Nicod
Journal:  Swiss Med Wkly       Date:  2007-06-30       Impact factor: 2.193

8.  Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and -extrinsic mechanisms.

Authors:  Baidong Hou; Boris Reizis; Anthony L DeFranco
Journal:  Immunity       Date:  2008-07-24       Impact factor: 31.745

9.  Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials.

Authors:  Ansar A Pathan; Clare R Sander; Helen A Fletcher; Ian Poulton; Nicola C Alder; Natalie E R Beveridge; Kathryn T Whelan; Adrian V S Hill; Helen McShane
Journal:  PLoS One       Date:  2007-10-24       Impact factor: 3.240

10.  Exosomes derived from M. Bovis BCG infected macrophages activate antigen-specific CD4+ and CD8+ T cells in vitro and in vivo.

Authors:  Pramod K Giri; Jeffrey S Schorey
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

View more
  4 in total

Review 1.  New findings of Toll-like receptors involved in Mycobacterium tuberculosis infection.

Authors:  Majid Faridgohar; Hassan Nikoueinejad
Journal:  Pathog Glob Health       Date:  2017-07-17       Impact factor: 2.894

2.  Alveolar epithelial cells are critical in protection of the respiratory tract by secretion of factors able to modulate the activity of pulmonary macrophages and directly control bacterial growth.

Authors:  Olga D Chuquimia; Dagbjort H Petursdottir; Natalia Periolo; Carmen Fernández
Journal:  Infect Immun       Date:  2012-11-12       Impact factor: 3.441

3.  Infection and RNA-seq analysis of a zebrafish tlr2 mutant shows a broad function of this toll-like receptor in transcriptional and metabolic control and defense to Mycobacterium marinum infection.

Authors:  Wanbin Hu; Shuxin Yang; Yasuhito Shimada; Magnus Münch; Rubén Marín-Juez; Annemarie H Meijer; Herman P Spaink
Journal:  BMC Genomics       Date:  2019-11-20       Impact factor: 3.969

4.  Macrophage control of phagocytosed mycobacteria is increased by factors secreted by alveolar epithelial cells through nitric oxide independent mechanisms.

Authors:  Dagbjort H Petursdottir; Olga D Chuquimia; Raphaela Freidl; Carmen Fernández
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.